- Epclusa® overall established cure rate across all 6 strains of Hepatitis C is roughly 96%
- For treatment experienced genotype 3 patients or for patients with advanced Liver cirrhosis (decompensated), treatment duration is 24 weeks instead of 12 weeks
- Epclusa®’s side effects profile is quite mild especially with enough water intake
- Consult a doctor before concurrent administration of other drugs and supplements to avoid drug interactions
- Epclusa® is approved by the FDA and EMA for use in adults and children aged six years and older or weighing at least 37 pounds (17 kilograms)
- You can visit the FixHepC forum to post any questions you may have about Hepatitis C treatment
Please refer to the originator’s website to learn all the information needed to use this medicine safely and effectively.